Home » Neuronetics’ MDD Therapy System Snags Shonnin Approval
Neuronetics’ MDD Therapy System Snags Shonnin Approval
Neuronetics received Japan’s Shonnin approval for a transcranial magnetic stimulation non-drug treatment option for major depressive disorder treatment.
The NeuroStar Advanced Therapy system uses MRI magnetic field pulses to non-invasively stimulate underactive areas of the brain delivering electroconvulsive therapy. It also provides real-time feedback to physicians.
The system has received approval for commercial distribution in the U.S. and it is CE marked.
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May